Adipositas und Kinderwunsch

Zusammenfassung

In Europa ist mit einer deutlichen Zunahme der Adipositas im fertilen Alter zu rechnen. Der Hausarzt wie auch der Frauenarzt sollten sich daher auf die Besonderheiten in der Betreuung übergewichtiger oder adipöser Patienten einstellen. Insbesondere im Zusammenhang mit einer präventivmedizinischen Betreuung von Patientinnen mit Kinderwunsch ist es wichtig, einige medizinische Fakten für das Beratungsgespräch parat zu haben. Die vorliegende Arbeit gibt einen kurzen Überblick über das Problem „Adipositas und Schwangerschaft” aus der Sicht des Frauenarztes.

Summary

In Europe it is anticipated that adiposity will rise considerably amongst women during their fertile years. General practitioners as well as gynaecologists should therefore become versed with the idiosyncrasies of the treatment of overweight or obese women. It is particularly important to have some medical facts at hand for the consultation for the preventative medical treatment of patients wishing to become pregnant. This paper gives a short summary of the problem „adiposity and pregnancy” from a the gynaecologists’ point of view

Schlüsselwörter

Schwangerschaft - Adipositas - Gestationsdiabetes

Keyword

Pregnancy - obesity - gestational diabetes

• Literatur

• 1 AWMF Leitlinie 057/008. Empfehlungen zu Diagnostik und Therapie des Gestationsdiabetes (GDM). (Download unter) http://leitlinien.net/
• 2 Bellver J, Pellicer A. Impact of obesity on spontaneous abortion. Am J Obstet Gynecol 2004; Jan; 190 (01) 293-294.
• 3 Buhling KJ. Diabetes und Schwangerschaft. CME Prakt Fortbild Gynäkol Geburtsmed Gynakol Endokrinol 2005; 01 (01) 34-43.
• 4 Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991; Oct; 165 (4 Part 1): 914-919.
• 5 Cedergren MI, Kallen BA. Maternal obesity and infant heart defects. Obes Res 2003; Sep; 11 (09) 1065-1071.
• 6 Clark AM, Thornley B, Tomlinson L. et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; Jun; 13 (06) 1502-1505.
• 7 Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; Jan 15; 338 (03) 147-152.
• 8 Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003; Jan; 79 (01) 1-13.
• 9 Crowther CA, Hiller JE, Moss JR. et al. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; Jun 16; 352 (24) 2477-2486.
• 10 Damm P, Kuhl C, Bertelsen A. et al. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992; Sep; 167 (03) 607-616.
• 11 Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; Sep; 191 (03) 964-968.
• 12 Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; Nov; 17 (11) 2858-2864.
• 13 Graf MA. PCO-Syndrom und Hyperandrogenämie. CME Praktische Fortbildung Gynakol Geburtsmed Gynakol Endokrinol 2006; 02 (03) 4-16.
• 14 Hebebrand J, Dabrock P, Lingenfelder M. et al. Ist Adipositas eine Krankheit?. Dtsch Arztebl 2004; 101: A2468-2474.
• 15 Huang DY, Usher RH, Kramer MS. et al. Determinants of unexplained antepartum fetal deaths. Obstet Gynecol 2000; Feb; 95 (02) 215-221.
• 16 Institute of Medicine - The National Academy of Science. Nutrition During Pregnancy. National Academic Press; 1990
• 17 Jakubowicz DJ, Iuorno MJ, Jakubowicz S. et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; Feb; 87 (02) 524-529.
• 18 Kabiru W, Raynor BD. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol 2004; Sep; 191 (03) 928-32.
• 19 Kemper I. Schwangerenbetreuung. In Bühling KJ, Friedmann W. Intensivkurs Gynäkologie und Geburtshilfe. München, Jena: Urban & Fischer; 2004
• 20 Kunzel W, Misselwitz B. Unexpected fetal death during pregnancy - a problem of unrecognized fetal disorders during antenatal care?. Eur J Obstet Gynecol Reprod Biol 2003; Sep 22; 110 (Suppl. 01) S86-S92.
• 21 Langer O, Rodriguez DA, Xenakis EM. et al. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 1994; Apr; 170 (04) 1036-1046.
• 22 Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005; Apr; 192 (04) 989-997.
• 23 Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; Jul; 19 (07) 1644-1646.
• 24 Mojtabai R. Body mass index and serum folate in childbearing age women. Eur J Epidemiol 2004; 19 (11) 1029-1036.
• 25 Nelson SM, Fleming R. Obesity and reproduction: impact and interventions. Curr Opin Obstet Gynecol 2007; Aug; 19 (04) 384-389.
• 26 Nohr EA, Bech BH, Davies MJ. et al. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 2005; Aug; 106 (02) 250-259.
• 27 Nohr EA, Bech BH, Vaeth M. et al. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2007; Jan; 21 (01) 5-14.
• 28 Oken E, Gillman MW. Fetal origins of obesity. Obes Res 2003; Apr; 11 (04) 496-506.
• 29 Polley BA, Wing RR, Sims CJ. Randomized controlled trial to prevent excessive weight gain in pregnant women. Int J Obes Relat Metab Disord 2002; Nov; 26 (11) 1494-1502.
• 30 Schoyer KD, Liu HC, Witkin S. et al. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome. Fertil Steril 2007; Jul; 88 (01) 139-144.
• 31 Sebire NJ, Jolly M, Harris JP. et al. Maternal obesity and pregnancy outcome: a study of 287.213 pregnancies in London. Int J Obes Relat Metab Disord 2001; Aug; 25 (08) 1175-1182.
• 32 Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; Jul; 102 (01) 181-192.
• 33 The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; Jan; 19 (01) 41-47.
• 34 Tian L, Shen H, Lu Q. et al. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab 2007; Apr; 92 (04) 1430-1433 Epub 2007 Jan 23.
• 35 Waller DK, Mills JL, Simpson JL. et al. Are obese women at higher risk for producing malformed offspring?. Am J Obstet Gynecol 1994; Feb; 170 (02) 541-548.
• 36 Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002; Jun; 10 (06) 551-554 PMID: 12055331 [PubMed - indexed for MEDLINE].
• 37 Watkins ML, Rasmussen SA, Honein MA. et al. Maternal obesity and risk for birth defects. Pediatrics 2003; May; 111 (5 Part 2): 1152-1158.
• 38 Weiss JL, Malone FD, Emig D. et al. FASTER Research Consortium. Obesity, obstetric complications and cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol 2004; Apr; 190 (04) 1091-1097.
• 39 Yu CK, Teoh TG, Robinson S. Obesity in pregnancy. BJOG 2006; Oct; 113 (10) 1117-1125.